期刊文献+

siRNA介导的间皮素基因沉默对卵巢癌裸鼠腹腔移植瘤生长的影响 被引量:6

Influence of mesothelin silence by siRNA on the growth of human ovarian xenografts in nude mice
下载PDF
导出
摘要 目的:研究间皮素(mesothelin,MSLN)基因被沉默后的卵巢癌细胞SKOV3-MSLN-shRNA增殖能力的变化,以及MSLN基因沉默对裸鼠卵巢癌腹腔移植瘤生长的影响。方法:利用针对MSLN基因的siRNA慢病毒液和对照组慢病毒液分别感染SKOV3细胞,建立SKOV3-MSLN-shRNA细胞和SKOV3-MSLN-neg细胞的稳定转染株;以SKOV3细胞作空白对照,用平板克隆形成法和细胞计数法检测3组细胞的增殖能力。应用3组细胞分别建立裸鼠卵巢癌腹腔移植瘤模型,2周后处死裸鼠,观察每组动物的成瘤率及每只裸鼠的肿瘤质量、肿瘤数目和肿瘤种植部位等。结果:SKOV3-MSLN-shRNA细胞的体外增殖能力明显低于SKOV3-MSLN-neg细胞和SKOV3细胞,差异有统计学意义(P<0.05)。SKOV3-MSLN-shRNA组裸鼠成瘤率为60%,而2个对照组SKOV3-MSLN-neg和SKOV3细胞的裸鼠成瘤率均为100%,差异无统计学意义(P>0.05)。SKOV3-MSLN-shRNA组动物的肿瘤数目、肿瘤质量及肿瘤种植部位明显低于2个对照组(P<0.05)。结论:MSLN基因沉默可以降低卵巢癌SKOV3细胞的体外增殖能力,同时可以抑制卵巢癌裸鼠腹腔移植瘤的生长和种植。 Objective:To study the influence of silencing mesothelin(MSLN) gene on the proliferation of ovarian cancer cell line SKOV3 in vitro the growth of human ovarian xenograft in nude mice in vivo.Methods:MSLN-silenced cells(SKOV3-MSLN-shRNA) and control cells(SKOV3-MSLN-neg) were established after being infected with RNA interference lentivirus and empty vector lentivirus,respectively.SKOV3 cells were used as blank control.Cell proliferation was assayed by clone formation test and cell counting assay.The xenografted model of the three cell lines were established in nude mice.After 2 weeks,the nude mice were sacrificed,and the tumor formation rate,tumor weight,tumor number,and tumor position were recorded.Results:The ability of proliferation of SKOV3-MSLN-shRNA cells was obviously decreased compared with SKOV3-MSLN-neg cells and SKOV3 cells in vitro.The difference was significant(P〈0.05).In vivo,the tumor formation rate was 60% in xenografts of SKOV3-MSLN-shRNA cells and 100% in other two groups.The difference was not significant(P〉0.05).The average tumor weight,tumor number,and number of tumor position were all decreased in SKOV3-MSLN-shRNA group compared with the two control groups(P〈0.05).Conclusion:Silencing MSLN gene decreased the proliferation of ovarian cancer SKOV3 cells in vitro and inhibited the growth of xenografts of ovarian cancer cells in nude mice
出处 《肿瘤》 CAS CSCD 北大核心 2010年第3期180-183,共4页 Tumor
基金 国家自然科学基金资助项目(编号:30572093) 河北省自然科学基金资助项目(编号:C2005000804)
关键词 卵巢肿瘤 基因沉默 异种移植模型抗肿瘤试验 间皮素 Ovarian neoplasms Gene silencing Xenograft model antitumor assays Mesothelin
  • 相关文献

参考文献11

  • 1HASSAN R, HO M. Mesothelin targeted cancer immunotherapy [J]. Eur J Cancer, 2008, 44( 1 ) :46-53.
  • 2吴小华,王小玲,张立芳,李利,王永军,郭燕红,郭清,杨波,黎海莉.卵巢上皮性肿瘤组织中间皮素和CA_(125)表达及其相关性研究[J].中华妇产科杂志,2005,40(10):709-711. 被引量:16
  • 3KANEKO O, GONG L, ZHANG J,et al. A binding domain on mesothelin for CA125/MUC16 [ J]. J Biol Chem,2009 , 284 (6) : 3739-3749.
  • 4王莉,李娜,吴小华.慢病毒介导的RNAi对卵巢癌细胞增殖及间皮素表达的影响[J].中国肿瘤生物治疗杂志,2008,15(2):134-138. 被引量:5
  • 5CREANEY J, BRUGGEN I, HOF M,et al. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma[ J]. Chest,2007, 132 (4) : 1239-1246.
  • 6GRIGORIU B, CHAHINE B, ZERIMECH F,et al. Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma [ J]. Clin Biochem ,2009, 42 (10/11 ) :1046- 1050.
  • 7HASSAN R, WILLIAMS-GOULD J, STEINBERG S M,et al. Tumordirected radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts [ J ]. Clin Cancer Res, 2006,12(16) :4983-4988.
  • 8王莉,李娜,吴小华,刘雅坤,崔宏银,李冬秀.间皮素和CA125在卵巢上皮性肿瘤中的共定位表达及临床意义[J].肿瘤,2009,29(4):358-362. 被引量:10
  • 9RUMP A, MORIKAWA Y, TANAKA M, et al. Binding of ovarian cancer antigen CA125/MUCI6 to mesothelin mediates cell adhesion [ J]. J Biol Chem,2004,279 (10) :9190-9198.
  • 10GUBBELS J A, BELISLE J, ONDA M,et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors [ J ]. Mol Cancer, 2006,5(1) : 50-65.

二级参考文献40

  • 1吴小华,王小玲,张立芳,李利,王永军,郭燕红,郭清,杨波,黎海莉.卵巢上皮性肿瘤组织中间皮素和CA_(125)表达及其相关性研究[J].中华妇产科杂志,2005,40(10):709-711. 被引量:16
  • 2陈书成,刘雅坤,吴小华,单保恩,陈兴,孙东霞,王莉.抗人可溶性间皮素相关蛋白单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2007,23(3):246-248. 被引量:5
  • 3CHANG K, PASTAN I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers[J]. Proc Natl Acad Sci USA,1996,93( 1 ) :136- 140.
  • 4BAST RC JR, BADGe-ELL D, LU Z, et al. New tumor markers: CA125 and beyond [ J ]. Int J Gynecol Cancer,2005,5 ( Suppl 3 ) : 274 -281.
  • 5RUMP A, MORIKAWA Y, TANAKA M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion[J].J Biol Chem ,2004 ,279(10) :9190-9198.
  • 6GUBBELS J A, BELISLE J, ONDA M, et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors[ J]. Mol Cancer, 2006,5( 1 ) :50-58.
  • 7HASSAN R, KREITMAN R J, PASTAN I, et al. Localization of mesothelin in epithelial ovarian cancer[ J ]. Appl Immunohistochem Mol Morphol,2005, 13 ( 3 ) :243-247.
  • 8HUANG C Y, CHENG W F, LEE C N, et al. Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor[ J ]. Anticancer Res ,2006,26 ( 6C ) :4721-4728.
  • 9BADGWELL D, LU Z, COI,E L, et al. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta suhunit and urinary hCG beta core fragment [ J ]. Gynecol Oncol,2007,106 ( 3 ) :490-497.
  • 10Chang K, Pastan I. Molecular cloning of mesothelin, differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci U S A, 1996, 93: 136- 140.

共引文献30

同被引文献70

  • 1王素梅,李力,张玮,黎丹戎,唐步坚.组织蛋白酶L基因真核表达质粒的构建与鉴定[J].广西医学院学报,2008,18(2):219-221. 被引量:2
  • 2陈书成,刘雅坤,吴小华,单保恩,陈兴,孙东霞,王莉.抗人可溶性间皮素相关蛋白单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2007,23(3):246-248. 被引量:5
  • 3DIAZ-MONTES T P,BRISTOW R E.Secondary cytoreduction for patients with recurrent ovarian cancer[J].Curr Oncol Rep,2005,7 (6):451-458.
  • 4MARKMAN M,BOOKMAN M A.Second-line treatment of ovarian cancer[J].Oncologist,2000,5 (1):26-35.
  • 5CHANG K,PASTAN I.Molecular cloning of mesothelin,a differentiation antigen present on mesothelium,mesotheliomas,and ovarian cancers[J].Proc Natl Acad Sci U S A,1996,93 (1):136-140.
  • 6HOUGH C D,SHERMAN-BAUST C A,PIZER E S,et al.Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer[J].Cancer Res,2000,60 (22):6281-6287.
  • 7ORD(ON)EZ N G.Application of mesothelin immunostaining in tumor diagnosis[J].Am J Surg Pathol,2003,27 (11):1418-1428.
  • 8LU K H,PATTERSON A P,WANG L,et al.Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis[J].Clin Cancer Res,2004,10 (10):3291-3300.
  • 9SCHANER M E, ROSS D T, CIARAVINO G,et al.Gene expression patterns in ovarian carcinomas[J].Mol Biol Cell,2003,14 (11):4376-4386.
  • 10YEN M J,HSU C Y,MAO T L,et al.Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma[J].Clin Cancer Res,2006,12 (3Pt1):827-831.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部